|
Volumn 77, Issue 6, 2006, Pages 712-
|
Anti-myelin antibodies in multiple sclerosis: Clinically useful?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI MYELIN ANTIBODY;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOGLOBULIN M ANTIBODY;
UNCLASSIFIED DRUG;
BIOLOGICAL MARKER;
MYELIN BASIC PROTEIN;
DISEASE COURSE;
EDITORIAL;
HUMAN;
LABORATORY TEST;
MULTIPLE SCLEROSIS;
OPTIC NEURITIS;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SEROCONVERSION;
WESTERN BLOTTING;
BLOOD;
CEREBROSPINAL FLUID;
IMMUNOLOGY;
NOTE;
PATHOLOGY;
PROGNOSIS;
REPRODUCIBILITY;
RISK FACTOR;
BIOLOGICAL MARKERS;
HUMANS;
IMMUNOGLOBULIN M;
MULTIPLE SCLEROSIS;
MYELIN BASIC PROTEINS;
PROGNOSIS;
RECURRENCE;
REPRODUCIBILITY OF RESULTS;
RISK FACTORS;
|
EID: 33646826116
PISSN: 00223050
EISSN: 1468330X
Source Type: Journal
DOI: 10.1136/jnnp.2006.089839 Document Type: Editorial |
Times cited : (9)
|
References (6)
|